$7.04
+0 (+0%)
At Close: Nov 14, 2025
180 Life Sciences Corp. Announces the Appointment of Russell T. Ray, MBA and Teresa DeLuca MD, MBA to Board of Directors
08:00am, Friday, 28'th May 2021
MENLO PARK, Calif., May 28, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the "Company"), a clinical-stage biotechnology company focused on the development of n
180 Life Sciences Corp. Receives Expected Notification From Nasdaq Related To Delayed Quarterly Report on Form 10-Q
04:45pm, Friday, 21'st May 2021
MENLO PARK, Calif., May 21, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), a clinical-stage biotechnology company focused on the develo
180 Life Sciences Corp. Receives Expected Notification From Nasdaq Related To Delayed Annual Report on Form 10-K
05:00pm, Monday, 19'th Apr 2021
MENLO PARK, Calif., April 19, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the "Company"), a clinical-stage biotechnology company focused on the developm
7 Reddit Penny Stocks to Buy for a Biotech Boom
01:52pm, Friday, 16'th Apr 2021
So, which biotech penny stocks, popular with the Reddit set, offer such opportunity? Consider these seven as ones with potential to live up to online enthusiasm.
180 Life Sciences Corp. Congratulates Dr. Lynn Williams on International Dupuytren Award 2021
08:15am, Wednesday, 14'th Apr 2021
Company actively pursuing Collagen VI pathway identified in peer-reviewed publication Company actively pursuing Collagen VI pathway identified in peer-reviewed publication
ATNF Stock: Over 30% Increase Intraday Explanation
04:06pm, Monday, 12'th Apr 2021
The stock price of 180 Life Sciences Corp (NASDAQ: ATNF) increased by over 30% during intraday trading. This is why it happened.
What's Happening With ATNF Stock And CELC Stock?
03:26pm, Monday, 12'th Apr 2021
180 Life Sciences Corp (NASDAQ: ATNF) shares are trading higher following insider buying from Marc Feldmann, a director on the company's board, and Jonathan Rothbard, the company's chief scientific of
5 Reddit Penny Stocks Seeing the Most Chatter Friday
10:45am, Friday, 09'th Apr 2021
Reddit penny stocks continue to be a hot subject among retail investors and we're looking at the most-talked-about ones today. The post 5 Reddit Penny Stocks Seeing the Most Chatter Friday appeared fi
DISCB and 6 Other Reddit Stocks Waiting for a Short Squeeze
02:10pm, Wednesday, 07'th Apr 2021
Reddit stocks continue to have the public's attention. These 7 could be the next short squeeze targets based on technical signs.
180 Life Sciences Continues Uptrend With Cannabinoid And Anti-Inflammatory Research
01:56am, Wednesday, 07'th Apr 2021
180 Life Sciences Continues Uptrend With Cannabinoid And Anti-Inflammatory Research
180 Life Science Rallies 18%: Technical Levels To Watch
05:12pm, Friday, 26'th Mar 2021
180 Life Sciences Corp. (NASDAQ: ATNF) shares rallied Friday, and there was no company evident news to explain the rise in shares. The stock closed up 18.5% at $6.96.
ATNF Stock: Why 180 Life Sciences Is Soaring Higher Today
03:44pm, Friday, 26'th Mar 2021
ATNF stock is soaring today, as investors digest a recent intriguing podcast the company released highlighting its long-term plans. The post ATNF Stock: Why 180 Life Sciences Is Soaring Higher Today a
ATNF Stock Price Increased Over 50% Pre-Market: Why It Happened
09:00am, Friday, 26'th Mar 2021
The stock price of 180 Life Sciences Corp (NASDAQ: ATNF) increased by over 50% pre-market. This is why it happened.
180 Life Sciences Corp. (NASDAQ: ATNF) Recognized R&D Pioneers in Anti-Inflammatory Therapeutics
08:30am, Friday, 26'th Mar 2021
NEW YORK, March 26, 2021 (GLOBE NEWSWIRE) -- NetworkNewsAudio – 180 Life Sciences Corp. (NASDAQ: ATNF) announces the availability of a broadcast titled, “Controlling Inflammation to Stop Disease.
180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Stockholders
08:30am, Wednesday, 24'th Mar 2021
MENLO PARK, Calif., March 24, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF, the "Company"), a clinical-stage biotechnology company with its lead indication in Phase 2b/3 clinical tr
Sign In
Buy ATNF